BIOVIA partnered with a major research-based pharmaceutical company specializing in the development of therapeutics across various disease areas, with a particular focus on genetic disorders. The company needed a solution to evaluate the effectiveness of various protocols for the assessment of myotonia using patient video recordings, both in the clinic and remote settings.
BIOVIA Pipeline Pilot enabled automation of data collection, pre-processing (eg, annotations and patient de-identification measures) and video analysis. AI and machine learning algorithms such as deep neural networks have been used for video analysis to create predictive models for characterizing the effectiveness of protocols for myotonia assessment. As a result, BIOVIA Pipeline Pilot helped expedite and improve decision-making, increased operational efficiency and productivity, and saved time and resources.
Read the use case to learn more.